Skip to main content

Global Coronary Heart Disease Diagnostic Imaging Devices Market to Experience 7% CAGR by 2030

 


The coronary heart disease diagnostic imaging devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving growth include the rising prevalence of coronary heart diseases, growth in the geriatric population, technological advancements in imaging devices, growing demand for non-invasive diagnostic techniques, adoption of sedentary lifestyles worldwide, rising awareness and early diagnosis of coronary heart disease, and increased R&D investments and grants for cardiovascular research.

Coronary Heart Disease (CHD) diagnostic imaging devices are medical technologies designed to generate detailed images of the heart, aiding in the diagnosis of CHD, a condition caused by plaque buildup in the coronary arteries, leading to reduced blood flow. These devices enable healthcare professionals to examine heart structures, evaluate blood circulation, and identify blockages or abnormalities in the coronary arteries. CHD diagnostic imaging technologies include X-ray machines, CT scanners, MRIs, and other advanced imaging systems that provide clear visualization of the heart and blood vessels.

Download a free sample report for in-depth market insights

https://meditechinsights.com/coronary-heart-disease-diagnostic-imaging-devices-market/request-sample/

Growing demand for non-invasive diagnostic techniques fuels its demand

With continuous technological advancements, non-invasive imaging has become essential not only for diagnosing Coronary Heart Disease (CHD) but also for guiding treatment decisions, assessing prognosis, and optimizing cost-effective, value-based care. Unlike traditional invasive procedures such as catheter-based coronary angiography, which pose risks of complications, extended recovery times, and higher medical expenses, advanced non-invasive imaging techniques including CT Coronary Angiography (CCTA), Cardiac MRI, Echocardiography, and Nuclear Imaging—offer safer, faster, and more precise diagnostic solutions. These modalities provide both functional and anatomical insights into coronary artery blockages, blood flow, and heart function, allowing for accurate disease assessment without surgical intervention. With increasing awareness of early CHD detection, growing healthcare investments, and the expanding use of AI-powered imaging technologies, demand for non-invasive diagnostic imaging is expected to rise significantly, further driving market growth.

Rising prevalence of CHD drives market growth

Coronary Heart Disease (CHD) is the most prevalent cardiovascular disease (CVD), causing nearly 9 million deaths annually, as reported by the World Health Organization (WHO). Its rising incidence is driven by factors such as an aging population, increasing obesity rates, diabetes, and hypertension. Additionally, urbanization and modern lifestyle changes have contributed to higher stress levels, unhealthy diets, and reduced physical activity, further elevating CHD risk. Since CHD often develops silently, with symptoms emerging in later stages, early detection through CHD imaging devices is essential. Accurate and timely diagnosis enables healthcare providers to make well-informed decisions, improving patient care by facilitating the development of optimal treatment plans. Furthermore, CHD imaging devices play a crucial role in monitoring disease progression, assessing treatment effectiveness, and detecting other cardiovascular conditions, fueling their growing demand.

Competitive Landscape Analysis

The global coronary heart disease diagnostic imaging devices market is marked by the presence of established and emerging market players such as Canon Medical Systems; Esaote SPA; FUJIFILM Holdings Corporation; GE Healthcare; Hitachi Medical Corporation; Koninkilijhe Phillips N. V.; SAMSUNG; Siemens Healthineers AG; Ziehm Imaging GmbH; Carestream Health; Shimadzu Corporation; Bracco Imaging S.p.A.; and Hologic, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

Unlock key data with a sample report for competitive analysis:

https://meditechinsights.com/coronary-heart-disease-diagnostic-imaging-devices-market/request-sample/

Global Coronary Heart Disease Diagnostic Imaging Devices Market Segmentation

This report by Medi-Tech Insights provides the size of the global coronary heart disease diagnostic imaging devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on modality and end user.

Market Size & Forecast (2023-2030), By Modality, USD Million

  • Computed Tomography (CT)
  • X rays Angiography (Fluoroscopy)
  • Ultrasound (Echocardiography)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging (PET & SPECT)

Market Size & Forecast (2023-2030), By End User, USD Million

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Imaging Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more